MedTrace Logo

Efficacy of Satisens® in Reducing Emotional Eating

NCT07079046 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2025-07-22

No results posted yet for this study

Summary

This study evaluates the efficacy of Satisens®, a dietary supplement composed of plant extracts, in reducing emotional eating and sweet cravings in healthy adults. The study will analyze hormonal, neurotransmitter, and inflammatory markers to understand the underlying mechanisms.

Conditions

  • Emotional Eating
  • Overweight or Obesity
  • Hormonal Changes
  • Neurotransmitter Agents
  • Food Cravings
  • Appetite Regulation
  • Body Weight
  • Inflammation Biomarkers

Interventions

DIETARY_SUPPLEMENT

Intervention 1: Satisens®

A dietary supplement composed of lemon verbena (Lippia citriodora), hibiscus (Hibiscus sabdariffa), saffron (Crocus sativus), and carob extract. Administered as 2 capsules daily with breakfast or lunch. Used to modulate appetite, emotional eating, and inflammatory markers.

DIETARY_SUPPLEMENT

Intervention 2: Placebo

Identical in appearance to the active supplement. Contains water with sucrose and no active ingredients. Administered as 2 capsules daily with breakfast or lunch.

Sponsors & Collaborators

  • VINABAS FORMULATIONS SL

    collaborator INDUSTRY

  • José Enrique de la Rubia Ortí, Ph

    lead OTHER

Principal Investigators

  • José Enrique Dr. de la Rubia Ortí, PhD in Pharmacy · Universidad Católica de Valencia San Vicente Mártir

  • Gonzalo Mariscal Ruiz-Rico · Universidad Católica de Valencia San Vicente Mártir

  • Ana Belén Carriquí Suárez · Facultad de Medicina y Ciencias de la Salud, Universidad Católica de Valencia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-31
Primary Completion
2026-01-31
Completion
2026-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07079046 on ClinicalTrials.gov